Beyond First Line CDK4/6 Inhibitors (CDK4/6i) and Aromatase Inhibitors (AI) in Patients with Oestrogen Receptor Positive Metastatic Breast Cancer (ER+ MBC): The Guy's Cancer Centre Experience. Issue 4 (April 2022)

Record Type:: Journal Article
Title:: Beyond First Line CDK4/6 Inhibitors (CDK4/6i) and Aromatase Inhibitors (AI) in Patients with Oestrogen Receptor Positive Metastatic Breast Cancer (ER+ MBC): The Guy's Cancer Centre Experience. Issue 4 (April 2022)
Main Title:: Beyond First Line CDK4/6 Inhibitors (CDK4/6i) and Aromatase Inhibitors (AI) in Patients with Oestrogen Receptor Positive Metastatic Breast Cancer (ER+ MBC): The Guy's Cancer Centre Experience
Authors:: Gousis, C.
Michoglou, K.
Lowe, H.
Kapiris, M.
Angelis, V.
Abstract:
Is Part Of:: Clinical oncology. Volume 34:Issue 4(2022)
Journal:: Clinical oncology
Issue:: Volume 34:Issue 4(2022)
Issue Display:: Volume 34, Issue 4 (2022)
Year:: 2022
Volume:: 34
Issue:: 4
Issue Sort Value:: 2022-0034-0004-0000
Page Start:: e178
Page End:
Publication Date:: 2022-04
Subjects:: Oncology -- Periodicals
Tumors -- Periodicals
Cancer -- Treatment -- Periodicals
Radiotherapy -- Periodicals
Neoplasms -- Periodicals
Cancer -- Radiotherapy
Cancer -- Treatment
Oncology
Medical radiology
Radiotherapy
Tumors
Electronic journals
Periodicals
616.994
Journal URLs:: http://www.sciencedirect.com/science/journal/09366555 ↗
http://www.elsevier.com/journal ↗
DOI:: 10.1016/j.clon.2021.12.030 ↗
Languages:: English
ISSNs:: 0936-6555
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3286.317000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 21031.xml